Ghana vs South Sudan: Access to anti-retroviral drugs, female
Ghana
51.0%
in 2024
South Sudan
51.0%
in 2024
Ghana rank
118th
South Sudan rank
118th
Access to anti-retroviral drugs, female over time
- Ghana
- South Sudan
How they compare
Ghana currently reports 51.0% against 51.0% in South Sudan, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was South Sudan ahead.
Ghana ranks 118th and South Sudan ranks 118th of 141 countries.
Ghana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.5% | 0.1% | 2.4% | Ghana |
| 2010s | 29.8% | 12.1% | 17.7% | Ghana |
| 2020s | 48.0% | 40.6% | 7.4% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Ghana or South Sudan?
- Ghana, at 51.0% against 51.0% in South Sudan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Ghana and South Sudan?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and South Sudan?
- 25 years are reported by both, from 2000 to 2024.
- How do Ghana and South Sudan rank globally for access to anti-retroviral drugs, female?
- Ghana ranks 118th and South Sudan ranks 118th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.